Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00602082

Locations


United Kingdom, England
	Addenbrooke's Hospital	Recruiting
	Cambridge, England, United Kingdom, CB2 2QQ
	Contact: Contact Person 44-1223-245-151
	Christie Hospital	Recruiting
	Manchester, England, United Kingdom, M20 4BX
	Contact: Contact Person 44-161-4468-8102
	Cookridge Hospital	Recruiting
	Leeds, England, United Kingdom, LS16 6QB
	Contact: Contact Person 44-113-267-3411
	Leicester Royal Infirmary	Recruiting
	Leicester, England, United Kingdom, LE1 5WW
	Contact: Contact Person 44-116-254-1414
	Mid Kent Oncology Centre at Maidstone Hospital	Recruiting
	Maidstone, England, United Kingdom, ME16 9QQ
	Contact: Contact Person 44-1622-729-000
	Northern Centre for Cancer Treatment at Newcastle General Hospital	Recruiting
	Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE
	Contact: Contact Person 44-191-233-6161
	Royal Marsden - Surrey	Recruiting
	Sutton, England, United Kingdom, SM2 5PT
	Contact: Contact Person 44-208-642-6044
	St. Thomas' Hospital	Recruiting
	London, England, United Kingdom, SE1 7EH
	Contact: Contact Person 44-207-188-7188
	UCL Cancer Institute	Recruiting
	London, England, United Kingdom, NW3 2QG
	Contact: Contact Person 44-207-794-2500

United Kingdom, Scotland
	Beatson West of Scotland Cancer Centre	Recruiting
	Glasgow, Scotland, United Kingdom, G12 0YN
	Contact: Contact Person 44-141-301-7057
	Edinburgh Cancer Centre at Western General Hospital	Recruiting
	Edinburgh, Scotland, United Kingdom, EH4 2XU
	Contact: Contact Person 44-131-537-1000

Sponsors and Collaborators

Cambridge University Hospitals NHS Foundation Trust

Investigators


Investigator:	Pippa Corrie, PhD, FRCP	Cambridge University Hospitals NHS Foundation Trust

Investigator:	Tim Meyer, MD, BSc, MRCP, PhD	UCL Cancer Institute